Nohara, Hirofumi <br/><br/>
Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases.  [electronic resource] 

 -  Biochemical and biophysical research communications  04 2020 
 - 332-339 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2020.01.081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line<br/>Enzyme Activation--drug effects<br/>Exenatide--adverse effects<br/>Glucagon-Like Peptide-1 Receptor--metabolism<br/>Hypoglycemic Agents--adverse effects<br/>Lung Diseases, Obstructive--drug therapy<br/>Mice, Inbred C57BL<br/>Mucins--genetics<br/>Up-Regulation--drug effects<br/>p38 Mitogen-Activated Protein Kinases--metabolism<br/>Glucagon-Like Peptide-1 Receptor Agonists